A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2001
12/20/2001	US20010053363 Novel amphipathic aldehydes and their uses as adjuvants and immunoeffectors
12/20/2001	US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct.
12/20/2001	DE10029201A1 Retarded release oral dosage form, obtained by granulating mixture containing active agent and polyvinyl acetate-polyvinyl pyrrolidone mixture below the melting temperature
12/20/2001	DE10028638A1 Storage-stable composition useful in cosmetic and pharmaceutical compositions comprises combination of glycerol monoalkyl ether with antioxidant
12/20/2001	CA2413160A1 Human tumor necrosis factor delta and epsilon
12/20/2001	CA2413149A1 Prodrug compounds with isoleucine
12/20/2001	CA2412842A1 Combination product for carrying out a cytotoxic treatment in a mammal
12/20/2001	CA2412811A1 Process for the manufacture of hydrogel compositions and hydrogel compositions manufactured thereby
12/20/2001	CA2412165A1 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
12/20/2001	CA2411967A1 Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
12/20/2001	CA2409431A1 Low molecular weight polymeric compositions
12/20/2001	CA2382065A1 Bioavailable dosage form of isotretinoin
12/19/2001	EP1164183A1 Solution for contact lenses
12/19/2001	EP1164171A2 Silicone compositions
12/19/2001	EP1163911A1 Glycoconjugates obtained from candida utilis cells and ricinus communis seeds
12/19/2001	EP1163908A1 Water-soluble complex of an extract of Ginkgo Bilboa, process for the preparation thereof and composition comprising the same
12/19/2001	EP1163906A2 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
12/19/2001	EP1163903A2 Methanal injection treatment for animal epidemics
12/19/2001	EP1163902A2 Transdermal preparation containing hydrophilic or salt-form drug
12/19/2001	EP1163901A1 Chewable soft capsules having improved administration properties and process for producing the same
12/19/2001	EP1163852A1 Masking agent
12/19/2001	EP1163273A1 Method for the reductive animation of polysaccharides
12/19/2001	EP1163272A1 Antibodies specific for cyp1b1
12/19/2001	EP1163234A1 Improved aqueous solubility pharmaceutical formulations
12/19/2001	EP1163209A1 Compounds and compositions for delivering active agents
12/19/2001	EP1163203A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
12/19/2001	EP1163012A1 Methods for inhibiting the formation of endoleaks associated with endovascular repair of abdominal aortic aneurysms
12/19/2001	EP1163011A2 Fatty acid-anticancer conjugates and uses thereof
12/19/2001	EP1163010A1 Hemoglobin-antioxidant conjugates
12/19/2001	EP1163009A1 Gel-microemulsion formulations
12/19/2001	EP1163008A1 Use of trehalose for stabilising a liquid vaccine
12/19/2001	EP1163007A1 Propofol formulation containing tris
12/19/2001	EP1163002A2 Polycationic carbohydrates as immunostimulants in vaccines
12/19/2001	EP1163001A2 Vaccine composition
12/19/2001	EP1162997A2 Staphylococcus antigen and vaccine
12/19/2001	EP1162994A1 A means for the prophylactic and therapeutic treatment of streptococcal infections
12/19/2001	EP1162992A2 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
12/19/2001	EP1162988A1 Wafer delivery system
12/19/2001	EP1162984A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
12/19/2001	EP1162982A2 Use of stabilised oligonucleotides for preparing a medicine with antitumour activity
12/19/2001	EP1162974A1 Quinazoline formulations and therapeutic use thereof
12/19/2001	EP1162972A2 Devices and methods for pain management
12/19/2001	EP1162958A1 Macromolecular pharmaceutical agent solubilized in aerosol propellant
12/19/2001	EP1162957A1 Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
12/19/2001	EP1162955A1 Nanoparticles, complexes with polynucleotides and their use
12/19/2001	EP1162954A1 Novel formulations comprising lipid-regulating agents
12/19/2001	EP1162953A2 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances
12/19/2001	EP1162950A1 Media in the form of complex dispersions, method for preparing same and uses
12/19/2001	EP1162947A2 Potentiation medium
12/19/2001	EP1162946A1 Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained
12/19/2001	EP1162945A1 Particle based vaccine composition
12/19/2001	EP1162943A1 Non-stinging coating composition
12/19/2001	EP1162915A1 Electromagnetic object detector provided with an additional electrode and intended for a medical radiation apparatus
12/19/2001	EP1162884A1 Oral low dose butyrate compositions
12/19/2001	EP1162883A1 Oral anti-odor compositions
12/19/2001	EP1102592A4 Coumarin and related aromatic-based polymeric prodrugs
12/19/2001	EP0914098A4 Multi-layered osmotic device
12/19/2001	EP0906092B1 Pharmaceutical compositions based on diclofenac
12/19/2001	EP0777451B1 Ophthalmic delivery system
12/19/2001	EP0766557B1 Topical compositions comprising n-acetyl-l-cysteine
12/19/2001	EP0758901B1 Formulations for il-11
12/19/2001	EP0750649B1 Branched polyoxaalkyl macromolecules, process for making them and their uses
12/19/2001	EP0683665B1 Magnetically responsive composition for carrying biologically active substances and methods of production and use
12/19/2001	EP0659073B1 Biodegradable polymer matrices for sustained delivery of local anesthetic agents
12/19/2001	EP0493485B1 Erection-inducing methods and compositions
12/19/2001	CN1327385A Anti-bacterial medicinal compositions
12/19/2001	CN1327382A Improved formulation for topical non-invasive application in vivo
12/19/2001	CN1327381A Aqueus medicinal compositions
12/19/2001	CN1326787A Montmorillonite as supplementary material for medicament
12/19/2001	CN1326733A Colon-releasing oral preparation and its preparing method
12/19/2001	CN1326732A Soft capsule containing vinyl ester and poly ether polymer, its use and producing method
12/19/2001	CN1076194C Pharmaceutical preparation
12/19/2001	CN1076186C Process for preparing plant tar-reducing agent and its use
12/18/2001	US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)
12/18/2001	US6331611 Expression and purification of cloned human alpha-fetoprotein
12/18/2001	US6331604 Grafted rubber-like silicone gel with enhanced oil compatibility and its synthetic process
12/18/2001	US6331540 Enhancing stability of aqueous pharmaceutical composition containing xanthan gum and fluoroquinolone antibiotic drug by adding water-soluble calcium salt
12/18/2001	US6331525 Targeted delivery of genes encoding interferon
12/18/2001	US6331524 Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy
12/18/2001	US6331520 Luteinizing hormone releasing hormone peptide agonist or antagonist; or growth hormone releasing factor peptide; nicontinamide aqueous solution
12/18/2001	US6331433 Human T cell leukemia cell line designated D1.1
12/18/2001	US6331398 Nucleic acid ligands
12/18/2001	US6331317 Pumping active agent and polymer through static mixer forming an emulsion, flowing through a manifold into quench liquid forming microparticles
12/18/2001	US6331316 2',3'-dideoxyinosine and methacrylic acid copolymer core; resistance to disintegration; drug release properties
12/18/2001	US6331313 Controlled-release biocompatible ocular drug delivery implant devices and methods
12/18/2001	US6331311 Injectable depot gel composition and method of preparing the composition
12/18/2001	US6331309 Hydrogel compositions for the controlled release administration of growth factors
12/18/2001	US6331306 Cosmetics, high water content yet viscosity of a cream, silicone emulsifying agent which is a dimethicone copolyol
12/18/2001	US6331299 Method for treatment of cancer and infectious disease and compositions useful in same
12/18/2001	US6331294 Use of copolymers of monoethylenically unsaturated carboxylic acids as solubilizers
12/18/2001	US6331289 Targeted diagnostic/therapeutic agents having more than one different vectors
12/18/2001	US6331205 Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules
12/18/2001	US6331175 Method and kit for imaging and treating organs and tissues
12/18/2001	CA2156901C Lipid-polymer conjugates and liposomes
12/18/2001	CA2143070C Oral controlled release liquid suspension pharmaceutical formulation
12/18/2001	CA2074215C Improved oral dosing formulations of dideoxy purine nucleosides
12/13/2001	WO2001094641A2 Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
12/13/2001	WO2001094585A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
12/13/2001	WO2001094547A2 Molecular delivery vehicle for delivery of selected compounds to targets
12/13/2001	WO2001093914A2 Multivalent platform molecules comprising high molecular weight polyethylene oxide

1 ... 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 ... 1712